SCHEMBL18735172

SCHEMBL18735172

CCOC(=O)CC(=O)SC(C)C(NC(=O)C(C)CC)C(=O)N(CC)CC

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SI P14410 1/20 0.33
▸ MGAM2 Q2M2H8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735162 0.90 MGAM (0.35) MGAMGAASIMGAM2
SCHEMBL18735192 0.90 — —
SCHEMBL18734946 0.88 — —
SCHEMBL18734953 0.88 MGAM (0.32) MGAMGAASIMGAM2
SCHEMBL18735147 0.88 LMNA (0.31) —
SCHEMBL18735062 0.86 MGAM (0.38) MGAMGAASIMGAM2
SCHEMBL18735191 0.85 GAA (0.35) MGAMGAASIMGAM2
SCHEMBL18734930 0.83 — —
SCHEMBL18734945 0.81 — —
SCHEMBL18735154 0.80 CNR2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback